Article
Gilead ties up with Tentarix for cancer, inflammatory disease therapies
Rating:
0.0
Views:
46
Likes:
1
Library:
1
Gilead Sciences said on Tuesday it had entered into an agreement with privately held Tentarix Biotherapeutics to develop therapies for cancer and inflammatory diseases.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value